ENDODIAGNOSIS
making endosure, The only tier 1 test for endometriosis, accessibleENDOSURE TEST has closed the 8.6-year diagnostic gap for an endometriosis diagnosis to minutes. Now available in Canadian clinics.
- Non-invasive & painless
- 30-minute test provides near-instant results
- High Accuracy: 99%+ (98% for those 36 years and older)
- Detects disease at all stages
- Appropriate for all ages: pre-menarche to post-menopause
- Results offer decision support for your clinician so a diagnosis, and treatment, can start sooner
How does it Work?
In under an hour, ENDOSURE test results support your clinician’s decisions
Fighting for Faster Diagnosis
Despite growing awareness of the condition, many women wait years to be diagnosed with endometriosis. We will change that.
After Diagnosis - What's next?
Diagnosis expedites the path to treatment, symptom management and stopping future disease progression.
closing the 5 year diagnositic gap
the Endometriosis diagnosis dilemma
Endometriosis affects 7% of women in Canada who face an average 5.4-year diagnostic delay.1 That’s 65 painful periods before getting diagnosis.
Diagnostic delays
The need for laparoscopy, the current gold standard for diagnosis, contributes to delays between onset of symptoms and diagnosis of endometriosis.

It was never in your head. It was in your gut.
Endometriosis can be a debilitating condition, presenting a variety of symptoms such as pelvic pain and infertility that affects quality of life. Until now rapid diagnostic testing that supported timely diagnosis and treatment was unavailable.
Now we can test for it.
Endosure™ determines if you have the GIMA biomarker or not. This diagnostic test provides clinicians with decision support so they can rapidly confirm endometriosis as the cause of menstrual or abdominal pain and infertility. This helps women receive care much earlier.

About Endometriosis
Endometriosis is an estrogen-dependent, frequently chronic inflammatory disease often associated with pelvic and abdominal pain, bloating, painful irregular bowel or urinary symptoms, and infertility. Diagnosis is difficult because symptoms overlap with other conditions, pain may become viewed as normal by the patient or treating clinicians, and there are limitations with current standard diagnostic testing for early disease. Symptomatic endometriosis has an estimated population prevalence of at least 10% globally, with most experiencing significant diagnostic delays of 3 to 11 years from onset of symptoms.2
A recent Canadian study reported a 7% population incidence with a 5.4 year diagnostic gap.1
Data of at-risk populations shows that 45% of adolescents and 55% of early adults have underlying endometriosis as the cause for regular dysmenorrhea.3
Years waiting for diagnosis
Diagnostic delays are 3 to 11 years, with an average of 8.6 years from time of presentation until diagnosis.
Women with endometriosis globally
Endometriosis affects roughly 10% (190 million) of reproductive age women and girls globally who can suffer from constant and intense pelvic pain, fatigue, depression, anxiety, and infertility.2
%
Suffer Pain Full Periods (Dysmenorrhea)
Up to 80% of women with dysmenorrhea have endometriosis. Needing a laparoscopy for diagnosis leads to years long waits that allows the disease to progress until pain levels warrant surgical risk.
%
Up to 90% of women with "unexplained infertility" have endometriosis
15% of endometriosis patients have no pain but struggle with infertility. Research shows endometriosis is the root cause of up to 90% of those with “unexplained infertility”.
Limited Appointments ARE available.
Book your Test.
Research
- Singh, S., et al; Prevalence, Symptomatic Burden, and Diagnosis of Endometriosis in Canada: Cross-Sectional Survey of 30000 Women, Journal of Obstetrics and Gynaecology Canada, Volume 42, Issue 7, 829 – 838
- World Health Organization. Endometriosis. Published March 24, 2023. Accessed November 25, 2024. https://www.who.int/news-room/fact-sheets/detail/endometriosis
- Nnoaham, Kelechi E. et al., Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries, Fertility and Sterility, Volume 96, Issue 2, 366 – 373.e8